PF
ANIP icon

Phoenix Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Phoenix Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7K Hold
15,000
– – ﹤0.01% 482
2025
Q4 		$13.7K Hold
15,000
– – ﹤0.01% 461
2025
Q3 		$13.7K Hold
15,000
– – ﹤0.01% 459
2025
Q2 		$10.6K Buy
+15,000
New +$977K ﹤0.01% 422

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Phoenix Financial's ANIP Position: Q1 2026 in Review

Phoenix Financial held its ANI Pharmaceuticals (ANIP) position steady in Q1 2026 at 15,000 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

Phoenix Financial first reported a position in ANIP in Q2 2025 and has held it in 4 quarters since. The position peaked at $13.7K in Q4 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Phoenix Financial held 15,000 shares of ANI Pharmaceuticals worth $11.7K as of Q1 2026.
  • Phoenix Financial left its ANI Pharmaceuticals share count unchanged in Q1 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Phoenix Financial's portfolio in Q1 2026, its #482 holding.
  • Phoenix Financial first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Phoenix Financial's ANI Pharmaceuticals position peaked at $13.7K in Q4 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.